AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
-6.32%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.88B
AUM Growth
+$2.88B
Cap. Flow
-$344M
Cap. Flow %
-11.96%
Top 10 Hldgs %
76.21%
Holding
111
New
12
Increased
16
Reduced
18
Closed
9

Top Buys

1
RUBY
Rubius Therapeutics, Inc
RUBY
$69.8M
2
FOLD icon
Amicus Therapeutics
FOLD
$13.3M
3
BABA icon
Alibaba
BABA
$10.7M
4
NIO icon
NIO
NIO
$10.5M
5
ANAB icon
AnaptysBio
ANAB
$9.98M

Top Sells

1
WW
WW International
WW
$432M
2
BPMC
Blueprint Medicines
BPMC
$15.6M
3
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$12.9M
4
GBT
Global Blood Therapeutics, Inc.
GBT
$9.04M
5
IMUX icon
Immunic
IMUX
$6.85M

Sector Composition

1 Healthcare 61.03%
2 Consumer Discretionary 37.81%
3 Technology 0.32%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
QTTB icon
76
Q32 Bio
QTTB
$20.9M
$2.29M 0.06% 100,000 – –
TGTX icon
77
TG Therapeutics
TGTX
$4.65B
$2.24M 0.06% 400,000 – –
IRWD icon
78
Ironwood Pharmaceuticals
IRWD
$214M
$2.04M 0.05% 110,532 -106,347 -49% -$1.96M
NVAX icon
79
Novavax
NVAX
$1.21B
$940K 0.02% 500,000 – –
TRIL
80
DELISTED
Trillium Therapeutics Inc.
TRIL
$870K 0.02% 150,000 – –
UBX
81
DELISTED
Unity Biotechnology
UBX
$815K 0.02% 50,000 -150,000 -75% -$2.45M
NVLN
82
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$759K 0.02% 256,400 – –
ATYR
83
aTyr Pharma
ATYR
$527M
$406K 0.01% 500,000 – –
IMDX
84
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
$375K 0.01% 150,000 – –
AAL icon
85
American Airlines Group
AAL
$8.82B
– – 0 – –
BAC icon
86
Bank of America
BAC
$376B
– – 0 – –
BMRN icon
87
BioMarin Pharmaceuticals
BMRN
$11.2B
– – 0 – –
BMY icon
88
Bristol-Myers Squibb
BMY
$96B
– – 0 – –
C icon
89
Citigroup
C
$178B
– – 0 – –
DVAX icon
90
Dynavax Technologies
DVAX
$1.19B
– – 0 – –
EXEL icon
91
Exelixis
EXEL
$10.1B
– – 0 – –
FBRX icon
92
Forte Biosciences
FBRX
$137M
– – -100,000 Closed -$934K
FCX icon
93
Freeport-McMoran
FCX
$63.7B
– – 0 – –
CBIO
94
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
– – -250,000 Closed -$4.03M
GM icon
95
General Motors
GM
$55.8B
– – 0 – –
GS icon
96
Goldman Sachs
GS
$226B
– – 0 – –
IBB icon
97
iShares Biotechnology ETF
IBB
$5.6B
– – 0 – –
IMUX icon
98
Immunic
IMUX
$80.9M
– – -1,000,000 Closed -$6.85M
KNSA icon
99
Kiniksa Pharmaceuticals
KNSA
$2.48B
– – -100,000 Closed -$1.74M
MS icon
100
Morgan Stanley
MS
$240B
– – 0 – –
1 2 3
4
5